ARGX:NASDAQ
argenx SE - ADR
919,21 US$
0,00%
(0,00) 1K
2-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoARGX tikeri uchun statistika yaratilmoqda...
Bozor kapitali
57,34 mlrd
Oʻrtacha hajm
257,81 ming
Hajmi
180,00
P/E koeffitsiyenti
34,92
52 haftalik eng yuqori
1 072,75 US$
52 haftalik eng past
661,85 US$
Aksiya boʻyicha daromad
26,32 US$
Beta
0,45
Muomaladagi aksiyalar
62,56 mln
Xodimlar soni
2 ming
Bozor kapitali
57,34 mlrd
Oʻrtacha hajm
257,81 ming
Hajmi
180,00
P/E koeffitsiyenti
34,92
52 haftalik eng yuqori
1 072,75 US$
52 haftalik eng past
661,85 US$
Aksiya boʻyicha daromad
26,32 US$
Beta
0,45
Muomaladagi aksiyalar
62,56 mln
Xodimlar soni
2 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
2 soat oldin
argenx presents Vyvgart data: Goldman lifts argenx stock target to EUR 982.00
Yahoo Finance
·
3 soat oldin
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
AD HOC NEWS
·
1 kun oldin
argenx stock falls 1.79 percent as Goldman raises its target
AD HOC NEWS
·
2 kun oldin
Argenx stock after-hours at EUR 815.70: minus 2.59 percent versus prior close
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
argenx SE - ADR haqida